HMGCL and malignant colon neoplasm: HMG-CoA lyase (HMGCL), which converts HMG-CoA to acetyl-CoA and a ketone body, could activate MEK1, and promote the proliferation of BRAF-positive melanoma and colon cancer cells (Zhao et al., 2017).